BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8898964)

  • 1. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
    Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
    Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell-mediated recognition of human trophoblast.
    Biassoni R; Bottino C; Millo R; Moretta L; Moretta A
    Semin Cancer Biol; 1999 Feb; 9(1):13-8. PubMed ID: 10092546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules.
    Sivori S; Vitale M; Sanseverino L; Parolini S; Barbaresi M; Bottino C; Moretta A
    Transplant Proc; 1996 Dec; 28(6):3199-203. PubMed ID: 8962240
    [No Abstract]   [Full Text] [Related]  

  • 8. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor.
    Pérez-Villar JJ; Carretero M; Navarro F; Melero I; Rodríguez A; Bottino C; Moretta A; López-Botet M
    J Immunol; 1996 Dec; 157(12):5367-74. PubMed ID: 8955184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
    Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
    Vance RE; Tanamachi DM; Hanke T; Raulet DH
    Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do NK cells sense the expression of HLA-G class Ib molecules?
    López-Botet M; Navarro F; Llano M
    Semin Cancer Biol; 1999 Feb; 9(1):19-26. PubMed ID: 10092547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of the CD94 receptor complex in costimulation of human natural killer cells.
    Voss SD; Daley J; Ritz J; Robertson MJ
    J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.
    Lazetic S; Chang C; Houchins JP; Lanier LL; Phillips JH
    J Immunol; 1996 Dec; 157(11):4741-5. PubMed ID: 8943374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.